HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gougopoulou, D. M. Articles by Spandidos, D. A. Search for Related Content PubMed PubMed Citation Articles by Gougopoulou, D. M. Articles by Spandidos, D. A.

Mutations and Expression of the ras Family Genes in Leukemias

^a Institute of Biological Research and Biotechnology, National Hellenic Research Foundation, Athens, Greece;
^b Medical School, University of Crete, Heraklion, Greece;
^c Department of Haematology, General Hospital of Athens, Athens, Greece.

Key Words. H-ras • K-ras • N-ras • Mutation • Expression • Leukemia

Professor Dr. D.A. Spandidos, University of Crete, Faculty of Medicine, PO Box 1393, Heraklion 71409, Crete, Greece.

The levels of expression and the incidence of codon 12 point mutation of the ras family genes were studied in 18 cases of leukemia, seven with acute myeloblastic leukemia (AML), three with acute lymphoblastic leukemia (ALL), four cases with chronic myelogenic leukemia (CML) and four cases with chronic lymphocytic leukemia (CLL). Elevated expression of the ras genes was found for 39%, 61% and 67% of the specimens for the H-ras, K-ras and N-ras, respectively. A trend was found between the overexpression of the N-ras gene and the acute leukemias: all 10 acute leukemias exhibited overexpression of the N-ras gene, while only two of the CML cases, both in blastic crisis, showed elevated levels of the N-ras gene. Codon 12 point mutations at the N-ras gene were found in two of seven cases (28%) with AML and one of the four cases (25%) with CML. The only K-ras codon 12 point mutation was found in a patient with CLL. No mutations were found in the codon 12 of H-ras. Our data suggest that apart from the point mutations, overexpression of the ras family genes is important in the development of the disease.

This article has been cited by other articles:

				C. Parikh, R. Subrahmanyam, and R. Ren Oncogenic NRAS, KRAS, and HRAS Exhibit Different Leukemogenic Potentials in Mice Cancer Res., August 1, 2007; 67(15): 7139 - 7146. [Abstract] [Full Text] [PDF]

				C. Parikh, R. Subrahmanyam, and R. Ren Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice Blood, October 1, 2006; 108(7): 2349 - 2357. [Abstract] [Full Text] [PDF]

				E. Barletta, G. Gorini, P. Vineis, L. Miligi, L. Davico, G. Mugnai, S. Ciolli, F. Leoni, M. Bertini, G. Matullo, et al. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents Carcinogenesis, May 1, 2004; 25(5): 749 - 755. [Abstract] [Full Text] [PDF]

				R. L. Darley, L. Pearn, N. Omidvar, M. Sweeney, J. Fisher, S. Phillips, T. Hoy, and A. K. Burnett Protein kinase C mediates mutant N-Ras-induced developmental abnormalities in normal human erythroid cells Blood, December 1, 2002; 100(12): 4185 - 4192. [Abstract] [Full Text] [PDF]